Stocks Archives - Page 4 of 171 - Money Morning - Only the News You Can Profit From
Hot Penny Stocks List for 2014
p>It wasn't hard for investors to find gains in 2013. This year is different – unless you're invested in one or more companies on this growing hot penny stocks list boasting huge year-to-date gains.
Leading the pack of 2014's surging low-priced stocks are biotech companies with promising new treatments in their pipeline. Also near the top are technology companies offering cutting edge products and solutions.
In mid-January, shares of Chelsea Therapeutics International Ltd (Nasdaq: CHTP) enjoyed a 91.74% one day surge to $4.49, skyrocketing as much as 120% intraday. The reason for the pop: An independent panel found the company's drug to treat a rare form of low blood pressure effective enough to warrant regulatory approval.To continue reading, please click here...
"Star Wars" Series Keeps Netflix Inc. (Nasdaq: NFLX) Momentum Rolling
NFLX stock climbed 1.7% yesterday and reached a record high of $439.35. DIS stock is up 1.7% today.
The sixth season of the series "Star Wars: the Clone Wars" will be available to subscribers in the United States and Canada starting March 7. The first five seasons ran on Time Warner Inc.'s (NYSE: TWX) Cartoon Network.
Netflix also announced that it will have exclusive U.S. streaming rights to Disney movies starting in 2016.To continue reading, please click here...
How to Trade Penny Stocks
Stocks are expected to end this year only modestly higher after last year's 30% gains, prompting investors to hunt for growth. One way to find it is by learning how to trade penny stocks.
Defined as stocks that trade under $5 a share, penny stocks have gotten a bad rap thanks to scams and manipulators. However, there are plenty of legitimate microcap companies offering lucrative opportunities.To continue reading, please click here...
Cadence Pharmaceuticals (Nasdaq: CADX) Stock Climbs 26% in Latest Biotech Deal
What a year so far for biotech stock profits…
Another consolidation in the active biotech sector came Tuesday when Cadence Pharmaceuticals Inc. (Nasdaq: CADX) agreed to be acquired by Mallinckrodt plc (NYSE: MNK) in a $1.3 billion deal. The move sent CADX up 26%.
Under terms of the deal, Dublin, Ireland-based Mallinckrodt will pay $14 in cash for each share of San Diego, Calif.-headquartered Cadence. That's a 26% premium to Monday's closing price and a 32% premium to the stock's average 30-day trading price.To continue reading, please click here...
Stock Market Sell-Off: The Chart That's Keeping Wall Street Up at Night
For months, Wall Street insiders have passed this chart around amongst themselves and nervously discussed whether it foretells a major stock market sell-off.
The chart compares the path of the current Dow Jones Industrial Average over the past year and a half to the Dow's moves over the 1928-1929 period.
While the Dow is trading at a much higher level now than in the 1928-1929 period, the pattern is eerily similar to the path that led to the worst stock market crash in Wall Street history, right up to the recent stock market sell-off and recovery.To continue reading, please click here...
Stocks to Buy: A Recent Sell-Off Gave Us This "Miracle Material" Bargain
I was one of the first analysts to pronounce this as the "Golden Age of Materials Science."
You know what I'm talking about – all those "Miracle Materials" that are changing our lives: There are the advanced composites that lighten our airliners; the great plastics that increase the "cool factor" of today's cars – while also making them safer and more economical. They include one of earth's more abundant resources, and the new discoveries, such as graphene, that promise to revolutionize biotechnology, computers, and industry.To continue reading, please click here...
Best Stocks to Buy Now: A Money Morning Weekly Recap
Best stocks to buy for the week ending Feb. 7, 2010: A robust two-day rally late last week helped the Dow Jones Industrial Average and the S&P 500 Index post their best week of the year, with gains of 0.6% and 0.8% respectively.
Despite the solid showing, the 30-stock index remains down 4.72% year to date. The S&P 500 is off 2.78% since the start of the year. And the Nasdaq, which rose 0.54% last week, is lower by 1.21% so far in 2014.
Indeed, this year has been marked by volatility, with the Dow swinging up or down at least 100 points in intraday trading on 25 out of 26 days since the start of the year.To continue reading, please click here...
Top 10 Penny Stocks in January 2014: Gains as High as 858%
Penny stock investing is attractive to those looking for huge gains in a short period of time, and the top 10 penny stocks of January 2014 prove that.
Each stock posted a gain of at least 97% in January alone – one gained an incredible 858%.
Investing in penny stocks can have its drawbacks and can be risky. But those investors who are prepared for the risks and jump on the right penny stock can double their money in days.
Just look at these top penny stocks last month.To continue reading, please click here...
The Best Biotech Takeover Targets for 2014
This could be the biggest year ever for investing in biotech takeover targets – all due to the patent cliff.
The "patent cliff" refers to the sharp revenue drop a pharmaceutical company faces when the patent on one of its drugs expires. At that point, other drug companies can begin replicating name-brand drugs, cutting into the billions of dollars in revenue that large-cap pharmaceutical companies are used to.To continue reading, please click here...